Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
boston blog main
boston
boston top stories
clinical trials
new york blog main
rna interference
san francisco blog main
alnylam pharmaceuticals
boehringer ingelheim
deals
eli lilly
mrna
national top stories
new york top stories
san francisco top stories
sanofi
startups
vc
alexion pharmaceuticals
alirocumab
alnylam
alnylam pharmaceutials
amgen
amy schulman
andreas klein
anna greka
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
barry greene
biology
biontech
cancer
car-t
caron jacobson
cigall kadoch
craig mello
What
medicines
6
×
rna
6
×
new
companies
based
deal
diseases
evidence
interference
long
molecules
mrna
pharma
small
treat
abandoning
addition
advance
ago
alltrna
alnylam
announced
aren’t
baggage
bets
betting
bio
biologics
called
cancer
car
cholesterol
comes
company
considered
curious
cut
cuts
cutting
data
Language
unset
Current search:
rna
×
medicines
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”